ArticleDrug safety2014
A description of signals during the first 18 months of the EMA pharmacovigilance risk assessment committee.
Alexandra C Pacurariu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
31 papers cite it
this paperpooled itcites it